Common Concern
Elevated PSA
Hearing that your PSA is elevated can be unsettling. The first thing to know is that an elevated PSA is not the same as prostate cancer. It starts a conversation and an evaluation. It is not a diagnosis.
(placeholder)
Elevated PSA at a Glance
What PSA Can Mean
- Benign prostate enlargement
- Inflammation or infection
- Normal biologic variation
- Increased prostate cancer risk
What Matters Most
- Prior PSA values and trend
- Age and prostate size
- Exam findings
- Family history and preferences
Possible Next Steps
- Repeat PSA testing
- Additional blood or urine markers
- Prostate MRI
- Biopsy when the risk justifies it
The Most Important Thing to Remember
An elevated PSA is not the same as having prostate cancer. PSA is a risk marker. It helps identify men who may need a closer look, but it does not tell us by itself whether cancer is present.
Most men evaluated for an elevated PSA do not ultimately have prostate cancer. The goal is to find clinically significant prostate cancer when it is present while helping other men avoid unnecessary biopsies and procedures.
What is PSA?
PSA stands for prostate-specific antigen. It is a protein made by prostate tissue and measured with a blood test. PSA is useful because prostate cancer can raise the PSA, but cancer is only one possible explanation.
PSA can also rise from benign prostate enlargement, inflammation, infection, recent procedures, and normal fluctuation. That is why I do not treat PSA like a simple positive-or-negative cancer test. I treat it as one piece of a larger risk assessment.
What happens at the first visit?
A first visit for elevated PSA is usually a careful review of the whole picture. I want to understand the number, but also the person behind the number.
We Review the PSA History
A PSA that has slowly changed over years may mean something different than one that has risen quickly. Trend often matters more than any single cutoff.
We Discuss Symptoms
Urinary symptoms, blood in the urine, blood in the semen, infection symptoms, and recent procedures can all affect how the PSA is interpreted.
We Consider Risk Factors
Age, family history, prostate size, exam findings, and other risk factors help determine whether observation, repeat testing, MRI, or biopsy makes sense.
We Talk About Your Goals
Some patients want to move quickly. Others are comfortable with a more stepwise approach. Your comfort with uncertainty is part of the decision.
Why repeat the PSA?
In many patients, repeating the PSA before moving to biopsy is a reasonable first step. PSA can vary because of laboratory differences, temporary inflammation, subclinical prostatitis, or normal biologic fluctuation.
Repeating the test is not ignoring the issue. It is a way to confirm whether the elevation is persistent and whether the trend is truly concerning. There are exceptions, especially when the exam, PSA pattern, or patient anxiety makes earlier MRI or biopsy more appropriate.
Why not biopsy everyone?
Biopsy is an important tool, but it is still a procedure. It can cause bleeding, infection risk, discomfort, anxiety, and downstream decisions that may not help every patient. If every elevated PSA automatically led to biopsy, many men would undergo procedures they did not need.
A biopsy decision should be based on the overall clinical picture, not PSA alone. PSA trend, MRI findings, exam findings, family history, biomarkers, prostate size, and patient preferences all matter.
How MRI fits into the evaluation
Prostate MRI can be very helpful, especially when the question is whether there is a suspicious area that should be targeted if biopsy is needed.
MRI Helps Stratify Risk
A good MRI can identify suspicious areas and help focus a biopsy on lesions that are more likely to represent clinically significant cancer.
A Normal MRI Is Reassuring, Not Perfect
A negative MRI lowers risk, but it does not eliminate it. Some clinically significant cancers may still be present despite a normal MRI.
A Suspicious MRI Is Not Always Cancer
MRI findings can be suspicious for reasons other than cancer. MRI results need to be interpreted with the PSA trend, exam, prostate size, and overall risk.
MRI Does Not Replace Biopsy
MRI improves planning and may help some patients avoid biopsy, but it is not a biopsy replacement when clinical concern remains high.
What if I need a biopsy?
It is completely normal to be nervous about prostate biopsy. If biopsy is recommended, the purpose is to answer a specific question: is there clinically significant prostate cancer that needs to be found?
Biopsy options may include an office transrectal biopsy, MRI fusion biopsy, or a transperineal biopsy. Some biopsies are done in the office, while MRI fusion or transperineal approaches may be done with sedation. The right approach depends on the MRI, infection risk, anatomy, comfort level, and the reason for biopsy.
We also talk through practical expectations. Temporary blood in the urine, stool, or semen can occur. Infection risk is discussed carefully, and antibiotics or a transperineal approach may be used when appropriate. Long-term erectile dysfunction is not expected from the biopsy itself.
Common Misconceptions
Elevated PSA means prostate cancer.
PSA starts an evaluation. It does not make a diagnosis. Many men with elevated PSA do not have prostate cancer.
A PSA under 4 means everything is normal.
A rising PSA can deserve attention even if it remains below a traditional cutoff. Context and trend matter.
A negative MRI rules out cancer.
A normal MRI reduces risk, but it does not eliminate the possibility of clinically significant prostate cancer.
A positive MRI means cancer.
Suspicious MRI findings are not always cancer. MRI helps guide the next step, but biopsy is what provides tissue diagnosis.
Every elevated PSA needs immediate biopsy.
Many patients benefit from repeat PSA, risk stratification, MRI, or biomarkers before deciding whether biopsy is needed.
All prostate cancers behave the same.
They do not. Low-risk disease is often monitored with active surveillance, while higher-risk disease may need staging and treatment.
My Perspective
I think about elevated PSA as a question, not an answer. The question is not simply, "Is the PSA above a certain number?" The better question is, "Given this patient's age, trend, exam, prostate size, family history, MRI findings, and preferences, what is the most thoughtful next step?"
My goal is to find clinically significant prostate cancer when it is present and worth finding. Just as important, I want to help men avoid unnecessary procedures when the risk is low enough to monitor safely.
That balance is why the evaluation is individualized. Sometimes the next step is a repeat PSA. Sometimes it is MRI. Sometimes it is biopsy. The point is to choose the step that fits the patient, not just the number.